Patients with cirrhosis frequently acquire profound hemostatic alterations, which may affect
thrombus quality and composition—factors that determine the susceptibility to embolization …

Acute liver injury (ALI), that is, the development of reduced liver function in patients without
preexisting liver disease, can result from a wide range of causes, such as viral or bacterial …

Introduction Coagulation dysfunction and thromboembolism emerge as strong comorbidity
factors in severe COVID‐19. However, it is unclear when particularly platelet activation …

Background Patients with acetaminophen (APAP)-induced acute liver failure (ALF) display
both hyper-and hypocoagulable changes not necessarily recapitulated by standard …

A State of the Art lecture titled “Thrombus Composition and Thrombolysis Resistance in
Stroke” was presented at the ISTH Congress in 2022. Intravenous thrombolysis (IVT) …

Craniomaxillofacial (CMF) reconstruction is a challenging clinical dilemma. It often
necessitates skin replacement in the form of autologous graft or flap surgery, which differ …

Background Obesity predisposes individuals to metabolic syndrome, which increases the
risk of cardiovascular diseases, non‐alcoholic fatty liver disease (NAFLD), and type 2 …

In classical amyloidoses, amyloid fibres form through the nucleation and accretion of protein
monomers, with protofibrils and fibrils exhibiting a cross-β motif of parallel or antiparallel β …

Patients with liver diseases are in a rebalanced state of hemostasis, due to simultaneous
decline in pro-and anticoagulant factors. This balance seems to remain even in the sickest …

Background The blood coagulation factor fibrin (ogen) can modulate inflammation by
altering leukocyte activity. Analyses of fibrin (ogen)‐mediated proinflammatory activity have …